Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 3Hepatitis C, Chronic 2Recurrence 1Liver Neoplasms 1Hepatitis C 1Hepatitis 1Bronchiolitis Obliterans Syndrome 1

Interventions

Ribavirin 4ledipasvir 2Sofosbuvir 2sofosbuvir-velpatasvir drug combination 1peginterferon alfa-2a 1ledipasvir, sofosbuvir drug combination 1daclatasvir 1Viusid 1Simeprevir 1Metformin 1Introns 1Dietary Supplements 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hepatitis C, Chronic × Sofosbuvir × Gastrointestinal × Clear all
NCT02771405 2026-04-13

FRI-STC

National Hepatology & Tropical Medicine Research Institute

Phase 3 Completed
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT02959359 2017-08-07

DAA in the Risk of Recurrence After Curative Treatment of HCC

Taipei Veterans General Hospital, Taiwan

Phase 4 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡